3.58
+0.24(+7.19%)
Currency In USD
| Previous Close | 3.34 |
| Open | 3.3 |
| Day High | 3.64 |
| Day Low | 3.21 |
| 52-Week High | 5.58 |
| 52-Week Low | 1.84 |
| Volume | 528,188 |
| Average Volume | 204,877 |
| Market Cap | 124.17M |
| PE | -2.65 |
| EPS | -1.35 |
| Moving Average 50 Days | 2.61 |
| Moving Average 200 Days | 3.68 |
| Change | 0.24 |
If you invested $1000 in Achieve Life Sciences, Inc. (ACHV) 10 years ago, it would be worth $0.71 as of June 01, 2025 at a share price of $3.58. Whereas If you bought $1000 worth of Achieve Life Sciences, Inc. (ACHV) shares 5 years ago, it would be worth $436.59 as of June 01, 2025 at a share price of $3.58.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 12:30 PM GMT
SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatm
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake
GlobeNewswire Inc.
May 20, 2025 12:30 PM GMT
Oral Presentation to Highlight Key Benefits of Cytisinicline’s Dual Mechanism of Action to Pulmonary SpecialistsSEATTLE and VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specia
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
GlobeNewswire Inc.
May 06, 2025 12:30 PM GMT
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatme